Patients were randomly assigned to receive an oral loading dose of trimetazidine 60 mg, or no such treatment, before percutaneous coronary intervention (PCI).

• 病人被随机地分成两组，实验组在经皮冠脉介入治疗前口服60毫克的曲美他嗪，对照组则不服用。